Search results for "Highlights"


 
Results 1 - 10 of about 221 for "Highlights".
Sort by: Relevance | Newest | Oldest

Score validated to assess patients with laryngeal symptoms for risk of GERD

In a study of 856 adults with chronic laryngeal symptoms, researchers created and validated a risk score, called COuGH RefluX, that is 79% sensitive and 81% specific for identifying gastroesophageal reflux disease (GERD).
https://gastroenterology.acponline.org/archives/2024/02/23/2.htm
23 Feb 2024

Subscribe

ACP Gastroenterology Monthly delivers a monthly summary of news in gastroenterology and hepatology, including the latest research, clinical guidelines, and FDA drug actions.
https://gastroenterology.acponline.org/subscribe/index.html

Undiagnosed liver disease frequently found among patients with cognitive impairment

Among 177,422 veterans with dementia and no prior cirrhosis diagnosis, 10.3% had a Fibrosis-4 score suggestive of advanced fibrosis and 5.3% had a score suggestive of cirrhosis.
https://gastroenterology.acponline.org/archives/2024/02/23/3.htm
23 Feb 2024

Spotlight on cholesterol and the liver

Very low low-density lipoprotein cholesterol levels are associated with increased risk of liver complications in the general population, a European study found, while a study of Chinese patients with primary biliary cholangitis showed that high total cholesterol levels predicted liver disease.
https://gastroenterology.acponline.org/archives/2024/02/23/5.htm
23 Feb 2024

AGA issues guidance on diet, nutrition in IBD

A new clinical practice update from the American Gastroenterological Association (AGA) covers the role of diet and nutritional therapies in managing inflammatory bowel disease (IBD) and identifying and treating malnutrition in IBD patients.
https://gastroenterology.acponline.org/archives/2024/02/23/1.htm
23 Feb 2024

Low-dose amitriptyline appears effective as second-line treatment for IBS

Patients with irritable bowel syndrome (IBS) who were randomized to titrated doses of a tricyclic antidepressant had significant improvements in their IBS symptom scores at six months compared to those receiving a placebo, a trial in primary care found.
https://gastroenterology.acponline.org/archives/2023/10/27/2.htm
27 Oct 2023

For ulcerative colitis, ustekinumab safe, effective through 4 years, industry study finds

Most patients who had symptomatic remission of their ulcerative colitis on the drug maintained it without corticosteroids, an extension of a randomized trial found.
https://gastroenterology.acponline.org/archives/2023/12/22/3.htm
22 Dec 2023

Thalidomide reduced bleeding in patients with small-intestinal angiodysplasia

A total of 68.6% of patients who were randomized to 100 mg of thalidomide daily (taken in four doses a day) had a reduction of at least 50% in bleeding episodes in the year after treatment compared to 16% of those on placebo.
https://gastroenterology.acponline.org/archives/2023/12/22/2.htm
22 Dec 2023

Alcohol abstinence not required for direct-acting antivirals to cure HCV, study finds

Restricting access to direct-acting antiviral therapy because of alcohol use creates an unnecessary barrier for patients with hepatitis C virus (HCV) infection, according to the authors of a recent study.
https://gastroenterology.acponline.org/archives/2023/10/27/1.htm
27 Oct 2023

GLP-1 receptor agonists may affect colonoscopy bowel prep

A retrospective cohort study found that patients taking glucagon-like peptide-1 (GLP-1) receptor agonists for diabetes or obesity had lower-quality bowel prep for colonoscopy and were more likely to be called back for a repeat test.
https://gastroenterology.acponline.org/archives/2023/10/27/3.htm
27 Oct 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next